Sun Pharmaceutical Industries, Ranbaxy sign pact with 2 plaintiff groups to settle claims

24 Mar 2022 Evaluate

Sun Pharmaceutical Industries along with its US-based arm Ranbaxy, Inc, has signed a $ 485 million settlement with two plaintiff groups regarding Ranbaxy generic drug application antitrust litigation. The case has been ongoing in the U.S. District Court for the District of Massachusetts (USA) for several years.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1849.05 0.00 (0.00%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.